Registration statement for securities of certain foreign private issuers

Statements of Cash Flows

v3.20.1
Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Operating activities:        
Net loss for the year $ (768,043) $ (28,282,880) $ (41,907,079) $ (22,639,272)
Items not involving cash:        
Amortization 14,095 6,175 32,555 29,041
Stock based compensation 228,576 251,357 1,651,119 1,505,625
Other share compensation   66,234
Warrant liability-fair value adjustment (1,117,476) 10,476,625 (19,800,645) (17,095,220)
Warrant liability-foreign exchange adjustment (51,091) (106,057) 17,687 (984,462)
Non-cash issuance costs 26,240 744,501  
Non-cash settlement included in payables 250,574      
Changes in non-cash working capital items:        
Amounts receivable, prepaid expenses and deposits 173,420 (1,577,929) 8,336,486 (6,508,259)
Accounts payable and accrued liabilities (1,227,919) 47,756 4,965,008 4,229,536
Cash used in operating activities (2,471,624) (19,184,953) (45,960,368) (41,396,777)
Financing activities:        
Net proceeds from issuance of common shares and warrants 3,477,427 31,377,908 35,766,754 27,158,114
Repayment of lease liabilities (3,946) (5,100)  
Cash provided by financing activities 3,473,481 31,377,908 35,761,654 27,158,114
Investing Activities:        
Cost of Patents (56,130) (53,758) (458,037) (420,587)
Cash used in investing activities (56,130) (53,758) (458,037) (420,587)
Decrease in cash and cash equivalents 945,727 12,139,197 (10,656,751) (14,659,250)
Cash and cash equivalents, beginning of the year 814,492 11,471,243 11,471,243 26,130,493
Cash and cash equivalents, end of the year 1,760,219 23,610,440 814,492 11,471,243
Cash and cash equivalents comprise:        
Cash 1,495,982 582,622 141,768 100,130
Cash equivalents 264,237 23,027,818 672,724 11,371,113
Cash and cash equivalents, end of the year $ 1,760,219 $ 23,610,440 $ 814,492 $ 11,471,243